Abstract:The present study aims to synthesize new thiadiazole/oxadiazole fused thiadiazole derivatives, incorporating pyridine moiety as effective inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) to treat Alzheimer disease. Initially, pyridine based thiosemicarbazone was synthesized by treating pyridine 2,6-dicarboxaldehyde with thiosemicarbazide. Thiosemicarbazone was cyclized into bis-thiadiazole, which further react with different isothiocyanates to give pyridine-based bis-(thiadiazole-fused-thiadiazole) derivatives (4a-h) . Next pyridine based semicarbazone was synthesized by treating pyridine 2,6-dicarboxaldehyde with semicarbazide. Then semicarbazone was cyclized into bis-oxadiazole which further react with different isothiocyanates to give pyridine-based bis-(oxadiazole-fused-thiadiazole) derivatives (7a-h) .The synthetic analogs were structurally elucidated through 1 H NMR, 13 C NMR and HRMS (EI) analysis and assessed for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory potential. All synthetic analogues showed varying degrees of inhibitory effects on AChE and BuChE, with IC 50 value ranging from 12.89 ± 1.10 μM - 61.76 ± 2.40 μM for AChE and 14.79 ± 1.20 μM - 56.87 ± 2.50 μM for BuChE in comparison of standard inhibitor Galantamine (IC 50 = 37.40 ± 1.20 μM for AChE and IC 50 = 41.20 ± 1.90 μM for BuChE). Among the series, analogues 4c IC 50 = 13.32 ± 1.30 μM (against AChE), and 15.17 ± 1.40 μM (against BuChE), and 7c IC 50 = 12.89 ± 1.10 μM (against AChE) and 14.79 ± 1.20 μM (against BuChE) exhibited notable inhibitory activity against AChE and BuChE enzymes, Moreover, molecular docking studies were conducted on potential analogues to investigate their binding interactions with the targeted enzyme's active sites.

Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Evaluating Quinolines: Molecular Dynamics Approach to Assess Their Potential as Acetylcholinesterase Inhibitors for Alzheimer's Disease.

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

2-(2-Indolyl-)-4(3h)-quinazolines Derivates As New Inhibitors of AChE: Design, Synthesis, Biological Evaluation and Molecular Modelling

Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold

Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies

6-acetyl-5H-thiazolo[3,2-a]pyrimidine derivatives as the novel acetylcholinesterase inhibitors: design, synthesis, and biological activity.

Synthesis, Biological Evaluation and Molecular Modeling of (E)- 3-Propargylene-1, 3-Dihydro-2h-indol-2-ones As Acetyl- and Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease

Design, Synthesis and Biological Evaluation of Pyrano[2,3-b]-naphthoquinone Derivatives as Acetylcholinesterase Inhibitors

Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer's Disease

Novel bis-thiazole-thiazolidinone hybrid derivatives: Synthesis, structural properties and anticholinesterase bioactive potential as drug competitor based on docking studies

Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, in vitro and in silico approaches of pyridine derived fused bis-oxadiazole and bis-thiadiazole derivatives

Synthesis and biological evaluation of novel aminoquinolines with an n-octyl linker: Impact of halogen substituents on C(7) or a terminal amino group on anticholinesterase and BACE1 activity

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Quinoline-Ferulic Acid Hybrids As Cholinesterase Inhibitors.

Discovery, Structure-Based Modification, In Vitro , In Vivo , and In Silico Exploration of m -Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning As Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors Against Alzheimer’s Diseases

Design, synthesis and biological evaluation of novel pyrazolone derivatives as selective butyrylcholinesterase inhibitors with antioxidant activity against Alzheimer's disease

Rapid Discovery and Crystallography Study of Highly Potent and Selective Butylcholinesterase Inhibitors Based on Oxime-Containing Libraries and Conformational Restriction Strategies